Please use this identifier to cite or link to this item:
|Web of Science®
|The mucopolysaccharidoses: advances in medical care lead to challenges in orthopaedic surgical care
|The Bone & Joint Journal, 2017; 99B(9):1132-1139
|British Editorial Society of Bone and Joint Surgery
|N. Williams, D. Challoumas, D. Ketteridge, P. J. Cundy, D. M. Eastwood
|The mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage disorders with clinical manifestations relevant to the orthopaedic surgeon. Our aim was to review the recent advances in their management and the implications for surgical practice. The current literature about MPSs is summarised, emphasising orthopaedic complications and their management. Recent advances in the diagnosis and management of MPSs include the recognition of slowly progressive, late presenting subtypes, developments in life-prolonging systemic treatment and potentially new indications for surgical treatment. The outcomes of surgery in these patients are not yet validated and some procedures have a high rate of complications which differ from those in patients who do not have a MPS. The diagnosis of a MPS should be considered in adolescents or young adults with a previously unrecognised dysplasia of the hip. Surgeons treating patients with a MPS should report their experience and studies should include the assessment of function and quality of life to guide treatment.
|©2017 The British Editorial Society of Bone & Joint Surgery
|Appears in Collections:
|Aurora harvest 3
Orthopaedics and Trauma publications
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.